BEECH GROVE — Police responded to a Walmart on the city's southern end after a gunshot was fired inside the store during a disturbance between two people, an official said.
No one was struck by gunfire, and police have taken in those involved in the altercation to determine what exactly occurred, said Beech Grove Deputy Police Chief Robert Mercuri.
Officers were dispatched at about 9 p.m. to the store, located at 4650 S. Emerson Ave. for a report of a possible shooting. Employees and customers were evacuated from the building around that time.
After police arrived, they discovered two people, both females, were involved in an altercation and at one point a single shot was fired. A third person tried to intervene in the dispute and got into a physical struggle, which left her with minor injuries, Mercuri said.
No employees were involved.
Police do not know the circumstances of the argument or exactly what occurred prior to a shot being fired. At this time it's not clear if either person involved in the dispute has been placed under arrest.
"The people involved are being detained by law enforcement while the investigation continues," Mercuri said.
Additional details were not immediately available.
-
Gun rights, sports bans, tariffs — key Supreme Court rulings on the horizon
From tariffs to gun rights to sports bans, the U.S. Supreme Court’s decisions this term could reshape interpretations of the Constitution on personal rights and presidential power.
Zedd returns to headline 2026 Indy 500 Snake Pit
Electronic superstar Zedd is coming back to Indianapolis Motor Speedway, set to headline the 2026 Indy 500 Coors Light Snake Pit.
Bill that could bring Chicago Bears to Indiana advances in House committee
The Chicago Bears moved closer to relocating to Indiana Thursday as a House committee unanimously passed legislation creating the framework to finance a new NFL stadium in Hammond.
FDA to drop two-study requirement for new drug approvals, aiming to speed access
The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs.